Relay Therapeutics' GAAP loss for 3 months of 2021 was $42.184 million, up 69.5% from $24.886 million in the prior year. Revenue was $0.952 million. The company did not generate revenue a year earlier.
Relay Therapeutics' GAAP loss for 3 months of 2021 was $42.184 million, up 69.5% from $24.886 million in the prior year. Revenue was $0.952 million. The company did not generate revenue a year earlier. 
ir.relaytx.com
English (US) 